Φορτώνει......
Response assessment using (68)Ga-PSMA ligand PET in patients undergoing (177)Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
PURPOSE: The first aim of this study was to evaluate (68)Ga-PSMA(HBED-CC) conjugate 11 positron emission tomography (PSMA PET) parameters for assessment of response to (177)Lu-PSMA-617 radioligand therapy (RLT) in patients with metastatic castration-resistant prostate cancer (mCRPC). The second aim...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Eur J Nucl Med Mol Imaging |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer Berlin Heidelberg
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6451716/ https://ncbi.nlm.nih.gov/pubmed/30569186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4236-4 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|